This is an old revision of this page, as edited by BD2412 (talk | contribs) at 03:17, 27 January 2014 (ref). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 03:17, 27 January 2014 by BD2412 (talk | contribs) (ref)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Kank-A" – news · newspapers · books · scholar · JSTOR (July 2009) (Learn how and when to remove this message) |
Kank-A is a liquid pharmaceutical product marketed by Blistex used primarily to treat canker sores. It is applied directly on the sore and works by numbing the local area (with benzocaine) to prevent discomfort and forming a protective mucous barrier with a compound benzoin tincture that protects the ulcer from further irritation, allowing it to heal more rapidly.
As of 2014, Kank-A comes in two varieties, the original providing oral pain relief against canker sores, and a soft gel that provides oral pain relief of toothaches.
References
- "Kank-A". Blistex.com. Retrieved 2013-03-17.
 | This product article is a stub. You can help Misplaced Pages by expanding it. |